Menu

Blog

Archive for the ‘neuroscience’ category: Page 141

Apr 12, 2023

What It’ll Take To Upload Our Brains To A Computer

Posted by in categories: biotech/medical, blockchains, computing, Elon Musk, ethics, life extension, neuroscience

As long as people have been alive, they’ve wanted to stay alive. But unlike finding the fountain of youth or becoming a vampire, uploading your brain to a computer or the cloud might actually be possible. Theoretically, we already know how to do it, and Elon Musk is even trying a brain implant with Neuralink. But technically, we have a long way to go. We explain the main technological advancements that we’ll need to make whole brain emulation a reality.

MORE TECHNOLOGY VIDEOS:
Why We Still Don’t Have Smart Contact Lenses.

Why We Still Haven’t Cloned Humans — It’s Not Just Ethics.

How Blockchain And Remote Monitoring Can Improve The Healthcare Experience.

Continue reading “What It’ll Take To Upload Our Brains To A Computer” »

Apr 12, 2023

Human Trial Suggests Clearing Plaques Slows Mental Decline

Posted by in categories: biotech/medical, life extension, neuroscience

Until now, it was unclear as to whether drugs that clear amyloid, which accumulate in the brain during aging and accompany diseases such as Alzheimer’s, have any influence over cognitive decline.

Previous studies have aimed to find this out, but results have been inconclusive due to study designs, hard-to-interpret data, and other issues that muddy the waters. March 10-14th saw the 15th International Conference on Alzheimer’s and Parkinson’s Diseases being held (virtually of course), where Dr. Mark Mintun of Eli Lilly presented data that, at least somewhat, affirmatively answers the question [1].

Apr 12, 2023

Researchers shows the key driver of Alzheimer’s disease

Posted by in categories: biotech/medical, neuroscience

Alzheimer’s disease is a neurodegenerative disease that affects millions of people worldwide. It is characterized by the accumulation of amyloid plaques and disordered protein fibers called tau tangles in the brain, which lead to cognitive impairment and dementia. Scientists have long been trying to understand the underlying mechanisms behind Alzheimer’s disease and find effective treatments for the condition.

Apr 12, 2023

Neural manifolds — The Geometry of Behaviour

Posted by in categories: mathematics, neuroscience

This video is my take on 3B1B’s Summer of Math Exposition (SoME) competition.

It explains in pretty intuitive terms how ideas from topology (or “rubber geometry”) can be used in neuroscience, to help us understand the way information is embedded in high-dimensional representations inside neural circuits.

Continue reading “Neural manifolds — The Geometry of Behaviour” »

Apr 12, 2023

Telomere Length Is Associated With Dementia Risk

Posted by in categories: biotech/medical, genetics, life extension, neuroscience

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Telomere Length Is Associated With Dementia Risk” »

Apr 12, 2023

Engineers 3D print soft, rubbery brain implants

Posted by in categories: 3D printing, neuroscience

Technique may enable speedy, on-demand design of softer, safer neural devices.

Apr 12, 2023

Endometriosis linked to increased risk of cardiovascular disease in women

Posted by in categories: biotech/medical, neuroscience

In a recent study published in the journal Maturitas, researchers conducted a systematic review and meta-analysis to compare the risk of cardiovascular events in women with and without endometriosis.

Study: Endometriosis and cardiovascular disease: A systematic review and meta-analysis. Image Credit: Bangkok Click Studio / Shutterstock.

Apart from autoimmune disorders, polycystic ovary syndrome, depression, and premature menopause, there are pregnancy-associated risk factors for cardiovascular diseases, such as gestational diabetes, pregnancy-related hypertensive disorders, placental abruption, preterm delivery, and pregnancy loss. Women experience a higher mortality rate due to cardiovascular diseases, and while the treatment methods are the same for men and women, the presentation, symptoms, diagnosis, risk factors, and response to treatment differ for women.

Apr 11, 2023

40 Years Ago, the CIA Tried to Decode Consciousness and Unlock Time Travel

Posted by in categories: neuroscience, time travel

The goal? To convert the energy of your mind and body into a kind of laser beam that can transcend spacetime.

Apr 11, 2023

“Can Consciousness be Explained?” — Royal Institute of Philosophy Annual Debate 2023

Posted by in categories: computing, neuroscience

How can flesh and blood brains give rise to pains and pleasures, dreams and desires, sights and sounds? Some believe this ‘hard problem’ of consciousness can never be solved. Can we expect any breakthroughs as the science of the mind progresses?

Our annual debate this year considers whether the problem of consciousness really is intractable. Our illustrious panel is neuroscientist Anil Seth and philosophers Louise Antony, Maja Spener and Philip Goff, with the BBC’s Ritula Shah chairing.

Continue reading “‘Can Consciousness be Explained?’ — Royal Institute of Philosophy Annual Debate 2023” »

Apr 11, 2023

The Yin and Yang of GABAergic and Glutamatergic Synaptic Plasticity: Opposites in Balance

Posted by in categories: genetics, neuroscience

Synaptic plasticity is a critical process that regulates neuronal activity by allowing neurons to adjust their synaptic strength in response to changes in activity. Despite the high proximity of excitatory glutamatergic and inhibitory GABAergic postsynaptic zones and their functional integration within dendritic regions, concurrent plasticity has historically been underassessed. Growing evidence for pathological disruptions in the excitation and inhibition (E/I) balance in neurological and neurodevelopmental disorders indicates the need for an improved, more “holistic” understanding of synaptic interplay. There continues to be a long-standing focus on the persistent strengthening of excitation (excitatory long-term potentiation; eLTP) and its role in learning and memory, although the importance of inhibitory long-term potentiation (iLTP) and depression (iLTD) has become increasingly apparent. Emerging evidence further points to a dynamic dialogue between excitatory and inhibitory synapses, but much remains to be understood regarding the mechanisms and extent of this exchange. In this mini-review, we explore the role calcium signaling and synaptic crosstalk play in regulating postsynaptic plasticity and neuronal excitability. We examine current knowledge on GABAergic and glutamatergic synapse responses to perturbances in activity, with a focus on postsynaptic plasticity induced by short-term pharmacological treatments which act to either enhance or reduce neuronal excitability via ionotropic receptor regulation in neuronal culture. To delve deeper into potential mechanisms of synaptic crosstalk, we discuss the influence of synaptic activity on key regulatory proteins, including kinases, phosphatases, and synaptic structural/scaffolding proteins. Finally, we briefly suggest avenues for future research to better understand the crosstalk between glutamatergic and GABAergic synapses.

Ligand-gated ion channel GABA type A receptors (GABAARs) mediate the majority of fast inhibition in the central nervous system, while glutamatergic AMPA receptors (AMPARs) and NMDA receptors (NMDARs) collectively mediate fast excitatory neurotransmission. NMDARs particularly play a unique role in synaptic plasticity due to high calcium permeability and voltage-dependent Mg2+ block typically relieved by AMPAR-mediated depolarization. Slow inhibition and excitation are generated by G protein-coupled, GABA type B (GABABRs) and metabotropic glutamate receptors (mGluRs), respectively. The concerted action of these receptors balances neuronal excitability. A close and coordinated spatial relationship between glutamatergic and GABAergic synapses on dendrites (Megías et al., 2001; Bleckert et al., 2013; Iascone et al., 2020), sometimes as near as on the same spine (Chen et al., 2012), facilitates synaptic input integration, dynamic calcium regulation, synaptic crosstalk, and coregulation.

Synaptic plasticity describes the ability of synapses to adapt their relative strength based on the overall level of activity or specific activity patterns, often by dynamic regulation of receptor-synaptic scaffold interactions or through trafficking. During development, it is heavily involved in dendritic growth, synaptogenesis, and the formation of neural circuits (reviewed in Akgül and McBain, 2016; Ismail et al., 2017; Jenks et al., 2021). In mature neurons, synaptic plasticity is responsible for synapse remodeling during experience. Genetic mutations or pathology leading to altered excitatory or inhibitory neurotransmission or impaired synaptogenesis typically result in deficits in synaptic plasticity, a common feature in neurodevelopmental and neurological disorders (Rudolph and Möhler, 2014; Mele et al., 2019), including autism (Hansel, 2019; Sohal and Rubenstein, 2019), down syndrome (Galdzicki et al., 2001; Schulz et al.